• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 CT 的骨骼肌减少症评估用于区分野生型和突变型胃肠道间质瘤。

CT-based assessment of sarcopenia for differentiating wild-type from mutant-type gastrointestinal stromal tumor.

机构信息

Department of Radiology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, People's Republic of China.

National Clinical Research Center for Geriatric Disorders (Xiangya Hospital), Central South University, Changsha, 410008, People's Republic of China.

出版信息

Sci Rep. 2023 Feb 24;13(1):3216. doi: 10.1038/s41598-022-27213-8.

DOI:10.1038/s41598-022-27213-8
PMID:36828845
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9958176/
Abstract

Non-invasive prediction for KIT/PDGFRA status in GIST is a challenging problem. This study aims to evaluate whether CT based sarcopenia could differentiate KIT/PDGFRA wild-type gastrointestinal stromal tumor (wt-GIST) from the mutant-type GIST (mu-GIST), and to evaluate genetic features of GIST. A total of 174 patients with GIST (wt-GIST = 52) were retrospectively identified between January 2011 to October 2019. A sarcopenia nomogram was constructed by multivariate logistic regression. The performance of the nomogram was evaluated by discrimination, calibration curve, and decision curve. Genomic data was obtained from our own specimens and also from the open databases cBioPortal. Data was analyzed by R version 3.6.1 and clusterProfiler ( http://cbioportal.org/msk-impact ). There were significantly higher incidence (75.0% vs. 48.4%) and more severe sarcopenia in patients with wt-GIST than in patients with mu-GIST. Multivariate logistic regression analysis showed that sarcopenia score (fitted based on age, gender and skeletal muscle index), and muscle fat index were independent predictors for higher risk of wt-GIST (P < 0.05 for both the training and validation cohorts). Our sarcopenia nomogram achieved a promising efficiency with an AUC of 0.879 for the training cohort, and 0.9099 for the validation cohort with a satisfying consistency in the calibration curve. Favorable clinical usefulness was observed using decision curve analysis. The additional gene sequencing analysis based on both our data and the external data demonstrated aberrant signal pathways being closely associated with sarcopenia in the wt-GIST. Our study supported the use of CT-based assessment of sarcopenia in differentiating the wt-GIST from the mu-GIST preoperatively.

摘要

在 GIST 中,对 KIT/PDGFRA 状态进行非侵入性预测是一个具有挑战性的问题。本研究旨在评估基于 CT 的肌肉减少症是否可以区分 KIT/PDGFRA 野生型胃肠道间质瘤(wt-GIST)和突变型 GIST(mu-GIST),并评估 GIST 的遗传特征。共回顾性分析了 2011 年 1 月至 2019 年 10 月间 174 例 GIST 患者(wt-GIST=52 例)。采用多变量逻辑回归构建肌肉减少症列线图。通过判别、校准曲线和决策曲线评估列线图的性能。基因组数据来自我们自己的标本,也来自开放数据库 cBioPortal。数据分析采用 R 版本 3.6.1 和 clusterProfiler(http://cbioportal.org/msk-impact)。与 mu-GIST 患者相比,wt-GIST 患者的发病率(75.0% vs. 48.4%)更高,肌肉减少症更严重。多变量逻辑回归分析显示,肌肉减少症评分(根据年龄、性别和骨骼肌指数拟合)和肌肉脂肪指数是 wt-GIST 风险较高的独立预测因素(训练和验证队列均 P<0.05)。我们的肌肉减少症列线图在训练队列中的 AUC 为 0.879,验证队列中的 AUC 为 0.9099,校准曲线一致性良好,具有良好的效率。决策曲线分析显示其具有良好的临床实用性。基于我们的数据和外部数据的额外基因测序分析表明,异常信号通路与 wt-GIST 中的肌肉减少症密切相关。本研究支持术前使用基于 CT 的肌肉减少症评估来区分 wt-GIST 和 mu-GIST。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb57/9958176/58539caf3b60/41598_2022_27213_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb57/9958176/0c10599ab7a6/41598_2022_27213_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb57/9958176/951446e37928/41598_2022_27213_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb57/9958176/6100ad89ec8c/41598_2022_27213_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb57/9958176/58539caf3b60/41598_2022_27213_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb57/9958176/0c10599ab7a6/41598_2022_27213_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb57/9958176/951446e37928/41598_2022_27213_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb57/9958176/6100ad89ec8c/41598_2022_27213_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb57/9958176/58539caf3b60/41598_2022_27213_Fig4_HTML.jpg

相似文献

1
CT-based assessment of sarcopenia for differentiating wild-type from mutant-type gastrointestinal stromal tumor.基于 CT 的骨骼肌减少症评估用于区分野生型和突变型胃肠道间质瘤。
Sci Rep. 2023 Feb 24;13(1):3216. doi: 10.1038/s41598-022-27213-8.
2
Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST).四重野生型胃肠道间质瘤(KIT/PDGFRA/SDH/RAS通路野生型胃肠道间质瘤)的综合基因组研究
BMC Cancer. 2014 Sep 20;14:685. doi: 10.1186/1471-2407-14-685.
3
[Clinicopathological features and prognosis of gastrointestinal stromal tumors with gene "homozygous mutation": a multicenter retrospective cohort study].基因“纯合突变”胃肠道间质瘤的临床病理特征及预后:一项多中心回顾性队列研究
Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Sep 25;24(9):804-813. doi: 10.3760/cma.j.cn.441530-20210720-00293.
4
Platelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1.血小板衍生生长因子受体-α通过稳定ETV1来调节KIT基因发生突变的胃肠道间质瘤细胞的增殖。
Gastroenterology. 2015 Aug;149(2):420-32.e16. doi: 10.1053/j.gastro.2015.04.006. Epub 2015 Apr 9.
5
qPCR in gastrointestinal stromal tumors: Evaluation of reference genes and expression analysis of KIT and the alternative receptor tyrosine kinases FLT3, CSF1-R, PDGFRB, MET and AXL.实时荧光定量 PCR 在胃肠道间质瘤中的应用:内参基因的评估及 KIT 和其他受体酪氨酸激酶(FLT3、CSF1-R、PDGFRB、MET 和 AXL)的表达分析。
BMC Mol Biol. 2010 Dec 20;11:100. doi: 10.1186/1471-2199-11-100.
6
The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST).KIT/血小板衍生生长因子受体A(PDGFRA)野生型(WT)胃肠道间质瘤(GIST)的渐进性碎片化
J Transl Med. 2017 May 23;15(1):113. doi: 10.1186/s12967-017-1212-x.
7
Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic.KIT/PDGFRA 野生型胃肠道间质瘤的分子亚型:来自美国国立卫生研究院胃肠道间质瘤临床中心的报告。
JAMA Oncol. 2016 Jul 1;2(7):922-8. doi: 10.1001/jamaoncol.2016.0256.
8
An overview on molecular biology of KIT/PDGFRA wild type (WT) gastrointestinal stromal tumours (GIST).KIT/PDGFRA 野生型(WT)胃肠道间质瘤(GIST)的分子生物学概述。
J Med Genet. 2013 Oct;50(10):653-61. doi: 10.1136/jmedgenet-2013-101695. Epub 2013 Jul 5.
9
Quadruple wild-type (WT) GIST: defining the subset of GIST that lacks abnormalities of KIT, PDGFRA, SDH, or RAS signaling pathways.四重野生型(WT)胃肠道间质瘤:定义缺乏KIT、PDGFRA、SDH或RAS信号通路异常的胃肠道间质瘤亚组。
Cancer Med. 2015 Jan;4(1):101-3. doi: 10.1002/cam4.325. Epub 2014 Aug 28.
10
Gastrointestinal stromal tumors with KIT exon 11 deletions are associated with poor prognosis.伴有KIT外显子11缺失的胃肠道间质瘤与预后不良相关。
Gastroenterology. 2006 May;130(6):1573-81. doi: 10.1053/j.gastro.2006.01.043.

本文引用的文献

1
KEGG for taxonomy-based analysis of pathways and genomes.KEGG 用于基于分类的途径和基因组分析。
Nucleic Acids Res. 2023 Jan 6;51(D1):D587-D592. doi: 10.1093/nar/gkac963.
2
CT-Based Sarcopenic Nomogram for Predicting Progressive Disease in Advanced Non-Small-Cell Lung Cancer.基于CT的肌肉减少症列线图预测晚期非小细胞肺癌的疾病进展
Front Oncol. 2021 Oct 8;11:643941. doi: 10.3389/fonc.2021.643941. eCollection 2021.
3
Myosteatosis predicting risk of transition to severe COVID-19 infection.肌内脂肪含量预测向重症 COVID-19 感染转变的风险。
Clin Nutr. 2022 Dec;41(12):3007-3015. doi: 10.1016/j.clnu.2021.05.031. Epub 2021 Jun 7.
4
Experimental Models of Sarcopenia: Bridging Molecular Mechanism and Therapeutic Strategy.肌少症的实验模型:连接分子机制与治疗策略。
Cells. 2020 Jun 2;9(6):1385. doi: 10.3390/cells9061385.
5
CT-assessed sarcopenia is a predictive factor for both long-term and short-term outcomes in gastrointestinal oncology patients: a systematic review and meta-analysis.CT 评估的肌肉减少症是胃肠道肿瘤患者长期和短期结局的预测因素:系统评价和荟萃分析。
Cancer Imaging. 2019 Dec 3;19(1):82. doi: 10.1186/s40644-019-0270-0.
6
EGF receptor (EGFR) inhibition promotes a slow-twitch oxidative, over a fast-twitch, muscle phenotype.表皮生长因子受体 (EGFR) 抑制促进了一种慢收缩氧化、快收缩的肌肉表型。
Sci Rep. 2019 Jun 25;9(1):9218. doi: 10.1038/s41598-019-45567-4.
7
Increased resting metabolism in neurofibromatosis type 1.1型神经纤维瘤病患者静息代谢增加。
Clin Nutr ESPEN. 2019 Aug;32:44-49. doi: 10.1016/j.clnesp.2019.05.006. Epub 2019 May 24.
8
DNA methylation in genes of longevity-regulating pathways: association with obesity and metabolic complications.长寿调节通路基因中的DNA甲基化:与肥胖及代谢并发症的关联
Aging (Albany NY). 2019 Mar 29;11(6):1874-1899. doi: 10.18632/aging.101882.
9
Relationship between Sarcopenia and mTOR Pathway in Patients with Colorectal Cancer: Preliminary Report.结直肠癌患者肌肉减少症与 mTOR 通路的关系:初步报告。
Nutr Cancer. 2019;71(1):172-177. doi: 10.1080/01635581.2018.1540716. Epub 2019 Jan 20.
10
Sarcopenia targeting with autophagy mechanism by exercise.运动靶向自噬机制治疗肌肉减少症。
BMB Rep. 2019 Jan;52(1):64-69. doi: 10.5483/BMBRep.2019.52.1.292.